Form 4: Astrana Health Director's Option Exercise and Share Sale

Astrana Health Director Thomas S. Lam exercised stock options and sold a portion of the resulting shares for tax purposes, as detailed in a recent SEC Form 4 filing.

Summary

• Director Thomas S. Lam of Astrana Health, Inc. (ASTH) reported transactions involving common stock.
• On December 8, 2025, Lam exercised options to acquire 29,502 shares of common stock at an exercise price of $17.78 per share.
• Concurrently, on December 8, 2025, Lam disposed of 25,866 shares of common stock at a price of $22 per share, typically for tax withholding related to the option exercise.
• Following these transactions, Lam directly beneficially owns 433,256 shares of common stock.
• Lam also indirectly beneficially owns 6,132,802 shares through Allied Physicians of California, a Professional Medical Corporation, and 1,133,706 shares through the Thomas and Jeanette Lam 2002 Family Trust.
• The direct ownership includes 77,500 shares of restricted stock vesting in three equal annual installments starting March 5, 2026, and 26,667 shares vesting upon achievement of certain pre-established performance goals.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions (option exercise and tax-related sale) which are neutral in sentiment and do not indicate significant positive or negative developments for the company.

Positives

• The exercise of stock options indicates a director's continued engagement and potential confidence in the company's long-term prospects.
• The sale price of $22 per share is higher than the exercise price of $17.78, indicating a gain on the exercised options.

Negatives

• A reduction in direct beneficial ownership by 25,866 shares, even if for tax purposes, slightly decreases the director's direct stake.

Risks

• The reporting person disclaims beneficial ownership of the 6,132,802 shares held by Allied Physicians of California, except to the extent of his pecuniary interest, which could be a point of clarification for investors regarding his true economic exposure.

Future Outlook

The filing indicates future vesting events for restricted stock, with 77,500 shares vesting in three equal annual installments beginning March 5, 2026, and an additional 26,667 shares vesting upon the achievement of specific performance goals.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, common across all industries, and does not provide specific insights into broader healthcare industry trends or competitive landscape for Astrana Health.

Related Party Transactions

• Indirect beneficial ownership of 6,132,802 shares through Allied Physicians of California, a Professional Medical Corporation, where the reporting person is CEO, CFO, director, and stockholder.
• Indirect beneficial ownership of 1,133,706 shares through the Thomas and Jeanette Lam 2002 Family Trust.

Stakeholder Impact

• Shareholders: Minor impact as these are routine insider transactions and do not signal a significant change in company fundamentals or strategy.
• Management: The director continues to hold a substantial stake, aligning his interests with shareholders.

Next Steps

• Vesting of 77,500 restricted shares in three equal annual installments beginning March 5, 2026.
• Vesting of 26,667 restricted shares upon achievement of certain pre-established performance goals.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions, specifically the exercise of stock options and a subsequent sale of shares for tax purposes. Such transactions are common and do not typically provide new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The director maintains a significant beneficial ownership, both direct and indirect. Therefore, a 'hold' recommendation is appropriate as there is no new information to alter an an existing investment thesis.

Keywords

Astrana Health, ASTH, Form 4, Insider Trading, Stock Options, Share Sale, Director Transactions, Thomas S. Lam, Beneficial Ownership, Restricted Stock